NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Viswanathan M, Golin CE, Jones CD, et al. Closing the Quality Gap: Revisiting the State of the Science (Vol. 4: Medication Adherence Interventions: Comparative Effectiveness). Rockville (MD): Agency for Healthcare Research and Quality (US); 2012 Sep. (Evidence Reports/Technology Assessments, No. 208.4.)

Cover of Closing the Quality Gap: Revisiting the State of the Science (Vol. 4: Medication Adherence Interventions: Comparative Effectiveness)

Closing the Quality Gap: Revisiting the State of the Science (Vol. 4: Medication Adherence Interventions: Comparative Effectiveness).

Show details

References

1.
Priority Areas for National Action: Transforming Health Care Quality Summary of Institute of Medicine report. Rockville, MD: Agency for Healthcare Research and Quality; Jan, 2003. www​.ahrq.gov/qual/iompriorities.htm.
2.
Pathman DE, Konrad TR, Freed GL, et al. The awareness-to-adherence model of the steps to clinical guideline compliance. The case of pediatric vaccine recommendations. Med Care. 1996 Sep;34(9):873–89. [PubMed: 8792778]
3.
Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005 Aug 4;353(5):487–97. [PubMed: 16079372]
4.
Cramer JA, Roy A, Burrell A, et al. Medication compliance and persistence: terminology and definitions. Value Health. 2008 Jan–Feb;11(1):44–7. [PubMed: 18237359]
5.
Urquhart J, Vrijens B. New findings about patient adherence to prescribed drug dosing regimens: an introduction to pharmionics. European Journal of Hospital Pharmacy Science. 2005;11(5):103–6.
6.
Vrijens B, Vincze G, Kristanto P, et al. Adherence to prescribed antihypertensive drug treatments: longitudinal study of electronically compiled dosing histories. BMJ. 2008 May 17;336(7653):1114–7. [PMC free article: PMC2386633] [PubMed: 18480115]
7.
Haynes RB, Ackloo E, Sahota N, et al. Interventions for enhancing medication adherence. Cochrane Database Syst Rev. 2008 Apr 16;(2):CD000011. [PubMed: 18425859]
8.
Paterson DL, Swindells S, Mohr J, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med. 2000 Jul 4;133(1):21–30. [PubMed: 10877736]
9.
Munger MA, Van Tassell BW, LaFleur J. Medication nonadherence: an unrecognized cardiovascular risk factor. MedGenMed. 2007;9(3):58. [PMC free article: PMC2100116] [PubMed: 18092064]
10.
The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993 Sep 30;329(14):977–86. [PubMed: 8366922]
11.
Lin V, Holman JR, Jamieson B. Clinical Inquiries: Which drugs should post-MI patients routinely receive? J Fam Pract. 2010 Sep;59(9):527–9. [PubMed: 20824230]
12.
Baker JG, Hill SJ, Summers RJ. Evolution of beta-blockers: from anti-anginal drugs to ligand-directed signalling. Trends Pharmacol Sci. 2011 Apr;32(4):227–34. [PMC free article: PMC3081074] [PubMed: 21429598]
13.
Expert Panel Report 3 (EPR-3): Guidelines for the Diagnosis and Management of Asthma-Summary Report 2007. J Allergy Clin Immunol. 2007 Nov;120(5 Suppl):S94–138. [PubMed: 17983880]
14.
LaRosa JC. Understanding risk in hypercholesterolemia. Clin Cardiol. 2003 Jan;26(1 Suppl 1):I3–6. [PubMed: 12539815]
15.
Glasgow RE, Hiss RG, Anderson RM, et al. Report of the health care delivery work group: behavioral research related to the establishment of a chronic disease model for diabetes care. Diabetes Care. 2001 Jan;24(1):124–30. [PubMed: 11194217]
16.
DiMatteo MR, Giordani PJ, Lepper HS, et al. Patient adherence and medical treatment outcomes: a meta-analysis. Med Care. 2002 Sep;40(9):794–811. [PubMed: 12218770]
17.
Krueger KP, Berger BA, Felkey B. Medication adherence and persistence: a comprehensive review. Adv Ther. 2005 Jul–Aug;22(4):313–56. [PubMed: 16418141]
18.
Noncommunicable Diseases and Mental Health Cluster. Adherence to Long Term Therapies: Evidence for Action. Geneva, Switzerland: World Health Organization; 2003.
19.
Peterson AM, Takiya L, Finley R. Meta-analysis of trials of interventions to improve medication adherence. Am J Health Syst Pharm. 2003 Apr 1;60(7):657–65. [PubMed: 12701547]
20.
Liu H, Golin CE, Miller LG, et al. A comparison study of multiple measures of adherence to HIV protease inhibitors. Ann Intern Med. 2001 May 15;134(10):968–77. [PubMed: 11352698]
21.
Wagner EH. Chronic disease management: what will it take to improve care for chronic illness? Eff Clin Pract. 1998 Aug–Sep;1(1):2–4. [PubMed: 10345255]
22.
World Health Organization. Adherence to Long Term Therapies: Evidence for Action. Switzerland: WHO; 2003.
23.
Management of MDD Working Group. VA/DoD clinical practice guideline for management of major depressive disorder (MDD) Version 2.0. US Department of Veteran Affairs, US Department of Defense; Washington, DC: May, 2009.
24.
Management of Asthma Working Group. VA/DoD clinical practice guideline for management of asthma in children and adults. Version 2.0. Washington (DC): Department of Veteran Affairs, Department of Defense; 2009.
25.
Management of Overweight and Obesity Working Group. A/DoD clinical practice guideline for screening and management of overweight and obesity. Version 1.0. Washington, DC: U.S. Department of Veterans Affairs, U.S. Department of Defense; 2006.
26.
Nunes V, Neilson J, O’Flynn N, et al. for the National Collaborating Centre for Primary Care. Clinical Guideline No. 76. National Institute for Health and Clinical Excellence and Royal College of General Practitioners; London: Jan, 2009. Medicines adherence involving patients in decisions about prescribed medicines and supporting adherence.
27.
New York State Department of Health. Adherence to antiretroviral therapy among HIV-infected patients with mental health disorders. New York: New York State Department of Health; 2006.
28.
Haynes RB, Ackloo E, Sahota N, et al. Interventions for enhancing medication adherence. Cochrane Database of Systematic Reviews. 2008;(2):CD000011. [PubMed: 18425859]
29.
World Health Organization. The world health report 2002: reducing risks, promoting healthy life. Geneva: World Health Organization; 2002. [PubMed: 14741909]
30.
Dunbar-Jacob J, Erlen JA, Schlenk EA, et al. Adherence in chronic disease. Annu Rev Nurs Res. 2000;18:48–90. [PubMed: 10918932]
31.
Sarquis LM, Dellacqua MC, Gallani MC, et al. Compliance in antihypertensive therapy: analyses in scientific articles. Rev Esc Enferm USP. 1998 Dec;32(4):335–53. [PubMed: 10896654]
32.
Schiff GD, Fung S, Speroff T, et al. Decompensated heart failure: symptoms, patterns of onset, and contributing factors. Am J Med. 2003 Jun 1;114(8):625–30. [PubMed: 12798449]
33.
Waeber B, Burnier M, Brunner HR. How to improve adherence with prescribed treatment in hypertensive patients? J Cardiovasc Pharmacol. 2000;35 Suppl 3:S23–6. [PubMed: 10854048]
34.
Psaty BM, Koepsell TD, Wagner EH, et al. The relative risk of incident coronary heart disease associated with recently stopping the use of beta-blockers. JAMA. 1990 Mar 23–30;263(12):1653–7. [PubMed: 1968518]
35.
Beckles GL, Engelgau MM, Narayan KM, et al. Population-based assessment of the level of care among adults with diabetes in the U.S. Diabetes Care. 1998 Sep;21(9):1432–8. [PubMed: 9727887]
36.
Rogers PG, Bullman W. Prescription medicine compliance: review of the baseline of knowledge – report of the National Council on Patient Information and Education. Journal of Pharmacoepidemiology. 1995;3:3–36.
37.
Mahoney JJ, ABJ, Fleming WK, Butterworth SW. The unhidden cost of noncompliance. J Manag Care Pharm. 2008;14(6-b):S1–S29.
38.
New England Healthcare Institute. Thinking outside the pillbox: A system-wide approach to improving patient medication adherence for chronic disease. 2009.
39.
Showalter A. Costs of patient noncompliance. Crystal Lake, IL: AlignMap; 2006. pp. 1–4.
40.
Task Force for Compliance. Noncompliance with medications: An economic tragedy with important implications for health care reform. 1994.
41.
Liebl A, Neiss A, Spannheimer A, et al. [Costs of type 2 diabetes in Germany. Results of the CODE-2 study]. Dtsch Med Wochenschr. 2001 May 18;126(20):585–9. [PubMed: 11402924]
42.
Holman HR, Lorig KR, Sobel DS, et al. Evidence that an education program for self-management of chronic disease can improve health status while reducing health care costs: a randomized trial. Abstr Book Assoc Health Serv Res Meet. 1997;14:19–20.
43.
Tuldra A, Fumaz CR, Ferrer MJ, et al. Prospective randomized two-Arm controlled study to determine the efficacy of a specific intervention to improve long-term adherence to highly active antiretroviral therapy. J Acquir Immune Defic Syndr. 2000 Nov 1;25(3):221–8. [PubMed: 11115952]
44.
Gibson PG, Coughlan J, Wilson AJ, et al. Self-management education and regular practitioner review for adults with asthma. Cochrane Database Syst Rev. 2000;(2):CD001117. [PubMed: 10796600]
45.
Sloss EM, Solomon DH, Shekelle PG, et al. Selecting target conditions for quality of care improvement in vulnerable older adults. J Am Geriatr Soc. 2000 Apr;48(4):363–9. [PubMed: 10798460]
46.
Mar J, Rodriguez-Artalejo F. Which is more important for the efficiency of hypertension treatment: hypertension stage, type of drug or therapeutic compliance? J Hypertens. 2001 Jan;19(1):149–55. [PubMed: 11204296]
47.
Massanari MJ. Asthma management: curtailing costs and improving patient outcomes. J Asthma. 2000 Dec;37(8):641–51. [PubMed: 11192228]
48.
Valenti WM. Treatment adherence improves outcomes and manages costs. AIDS Read. 2001 Feb;11(2):77–80. [PubMed: 11279875]
49.
Golin CE, Liu H, Hays RD, et al. A prospective study of predictors of adherence to combination antiretroviral medication. J Gen Intern Med. 2002 Oct;17(10):756–65. [PMC free article: PMC1495120] [PubMed: 12390551]
50.
Bosworth HB, Dudley T, Olsen MK, et al. Racial differences in blood pressure control: potential explanatory factors. Am J Med. 2006 Jan;119(1):70 e9–15. [PubMed: 16431192]
51.
Gifford AL, Bormann JE, Shively MJ, et al. Predictors of self-reported adherence and plasma HIV concentrations in patients on multidrug antiretroviral regimens. J Acquir Immune Defic Syndr. 2000 Apr 15;23(5):386–95. [PubMed: 10866231]
52.
Bryson CL, Au DH, Sun H, et al. Alcohol screening scores and medication nonadherence. Ann Intern Med. 2008 Dec 2;149(11):795–804. [PubMed: 19047026]
53.
Kilbourne AM, Reynolds CFr, Good CB, et al. How does depression influence diabetes medication adherence in older patients? Am J Geriatr Psychiatry. 2005 Mar;13(3):202–10. [PubMed: 15728751]
54.
Muma RD, Ross MW, Parcel GS, et al. Zidovudine adherence among individuals with HIV infection. AIDS Care. 1995;7(4):439–47. [PubMed: 8547359]
55.
Laine C, Newschaffer CJ, Zhang D, et al. Adherence to antiretroviral therapy by pregnant women infected with human immunodeficiency virus: a pharmacy claims-based analysis. Obstet Gynecol. 2000 Feb;95(2):167–73. [PubMed: 10674574]
56.
Schlenk EA, Dunbar-Jacob J, Engberg S. Medication non-adherence among older adults: a review of strategies and interventions for improvement. J Gerontol Nurs. 2004 Jul;30(7):33–43. [PubMed: 15287325]
57.
U.S. Department of Health and Human Services. Washington, DC: U.S. Government Printing Office; 2000. Healthy People 2010. Originally developed for Ratzan SC, Parker RM. Introduction. In National Library of Medicine Current Bibliographies in Medicine: Health Literacy. Selden CR, Zorn M, Ratzan SC, Parker RM, Editors. NLM Pub. No. CBM 2000-1. Bethesda, MD: National Institutes of Health, U.S. Department of Health and Human Services; 2000.
58.
Pignone M, DeWalt DA, Sheridan S, et al. Interventions to improve health outcomes for patients with low literacy. A systematic review. J Gen Intern Med. 2005 Feb;20(2):185–92. [PMC free article: PMC1490066] [PubMed: 15836553]
59.
Williams MV, Baker DW, Parker RM, et al. Relationship of functional health literacy to patients’ knowledge of their chronic disease. A study of patients with hypertension and diabetes. Arch Intern Med. 1998 Jan 26;158(2):166–72. [PubMed: 9448555]
60.
TenHave TR, Van Horn B, Kumanyika S, et al. Literacy assessment in a cardiovascular nutrition education setting. Patient Educ Couns. 1997 Jun;31(2):139–50. [PubMed: 9216355]
61.
Baker DW, Gazmararian JA, Williams MV, et al. Functional health literacy and the risk of hospital admission among Medicare managed care enrollees. Am J Public Health. 2002 Aug;92(8):1278–83. [PMC free article: PMC1447230] [PubMed: 12144984]
62.
Baker DW, Parker RM, Williams MV, et al. Health literacy and the risk of hospital admission. J Gen Intern Med. 1998 Dec;13(12):791–8. [PMC free article: PMC1497036] [PubMed: 9844076]
63.
Schillinger D, Grumbach K, Piette J, et al. Association of health literacy with diabetes outcomes. JAMA. 2002 Jul 24–31;288(4):475–82. [PubMed: 12132978]
64.
Schillinger D, Barton LR, Karter AJ, et al. Does literacy mediate the relationship between education and health outcomes? A study of a low-income population with diabetes. Public Health Rep. 2006 May–Jun;121(3):245–54. [PMC free article: PMC1525295] [PubMed: 16640146]
65.
Welk G, Wood K, Jones S, et al. The validity of three different accelerometers for assessment of lifestyle physical activity. Med Science Sports Exercise. 1999;31:S142.
66.
Kalichman SC, Ramachandran B, Catz S. Adherence to combination antiretroviral therapies in HIV patients of low health literacy. J Gen Intern Med. 1999 May;14(5):267–73. [PMC free article: PMC1496573] [PubMed: 10337035]
67.
Sawaya AL, Tucker K, Tsay R, et al. Evaluation of four methods for determining energy intake in young and older women: comparison with doubly labeled water measurements of total energy expenditure. Am J Clin Nutr. 1996 Apr;63(4):491–9. [PubMed: 8599311]
68.
Sheridan SL, Halpern DJ, Viera AJ, et al. Interventions for individuals with low health literacy: a systematic review. J Health Commun. 2011 Sep 30;16 Suppl 3:30–54. [PubMed: 21951242]
69.
Berkman ND, Sheridan SL, Donahue KE, et al. Low health literacy and health outcomes: an updated systematic review. Ann Intern Med. 2011 Jul 19;155(2):97–107. [PubMed: 21768583]
70.
Paasche-Orlow MK, Riekert KA, Bilderback A, et al. Tailored education may reduce health literacy disparities in asthma self-management. Am J Respir Crit Care Med. 2005 Oct 15;172(8):980–6. [PMC free article: PMC2718412] [PubMed: 16081544]
71.
Kim S, Love F, Quistberg DA, et al. Association of health literacy with self-management behavior in patients with diabetes. Diabetes Care. 2004 Dec;27(12):2980–2. [PubMed: 15562219]
72.
Miller LG, Liu H, Hays RD, et al. Knowledge of antiretroviral regimen dosing and adherence: a longitudinal study. Clin Infect Dis. 2003 Feb 15;36(4):514–8. [PubMed: 12567311]
73.
Eaton ML, Holloway RL. Patient comprehension of written drug information. Am J Hosp Pharm. 1980 Feb;37(2):240–3. [PubMed: 7361799]
74.
de Bruin M, Viechtbauer W, Schaalma HP, et al. Standard care impact on effects of highly active antiretroviral therapy adherence interventions: A meta-analysis of randomized controlled trials. Arch Intern Med. 2010 Feb 8;170(3):240–50. [PubMed: 20142568]
75.
Shojania KG, McDonald KM, Wachter R, et al. Volume 1—Series Overview and Methodology Technical Review 9. Rockville, MD: Agency for Healthcare Research and Quality; 2004. Closing the Quality Gap: A Critical Analysis of Quality Improvement Strategies. (Contract No. 290-02-0017 to the Stanford University-UCSF Evidence-based Practice Center) AHRQ Publication No. 04-005101. www​.ahrq.gov/clinic/tp/gaprevover.htm.
76.
Institute of Medicine (U.S.), Committee on Identifying Priority Areas for Quality Improvement. Priority areas for national action: transforming health care quality. Washington, DC: National Academies Press; 2003.
77.
Roter DL, Hall JA, Merisca R, et al. Effectiveness of interventions to improve patient compliance: a meta-analysis. Med Care. 1998 Aug;36(8):1138–61. [PubMed: 9708588]
78.
Lee JK, Grace KA, Taylor AJ. Effect of a pharmacy care program on medication adherence and persistence, blood pressure, and low-density lipoprotein cholesterol: a randomized controlled trial. JAMA. 2006 Dec 6;296(21):2563–71. [PubMed: 17101639]
79.
Crepaz N, Lyles CM, Wolitski RJ, et al. Do prevention interventions reduce HIV risk behaviours among people living with HIV? A meta-analytic review of controlled trials. AIDS. 2006 Jan 9;20(2):143–57. [PubMed: 16511407]
80.
Simoni JM, Pearson CR, Pantalone DW, et al. Efficacy of interventions in improving highly active antiretroviral therapy adherence and HIV-1 RNA viral load. A meta-analytic review of randomized controlled trials. J Acquir Immune Defic Syndr. 2006 Dec 1;43 Suppl 1:S23–35. [PMC free article: PMC4044045] [PubMed: 17133201]
81.
Amico KR, Harman JJ, Johnson BT. Efficacy of antiretroviral therapy adherence interventions: a research synthesis of trials, 1996 to 2004. J Acquir Immune Defic Syndr. 2006 Mar;41(3):285–97. [PubMed: 16540929]
82.
Simoni JM, Amico KR, Smith L, et al. Antiretroviral adherence interventions: translating research findings to the real world clinic. Curr HIV/AIDS Rep. 2010 Feb;7(1):44–51. [PMC free article: PMC3607373] [PubMed: 20425057]
83.
Agency for Healthcare Research and Quality. Methods guide for effectiveness and comparative effectiveness reviews. 2011.
84.
Viswanathan M, Berkman ND. Development of the RTI item bank on risk of bias and precision of observational studies. J Clin Epidemiol. 2011 Sep 28 [PubMed: 21959223]
85.
Owens DK, Lohr KN, Atkins D, et al. AHRQ series paper 5: grading the strength of a body of evidence when comparing medical interventions--agency for healthcare research and quality and the effective health-care program. J Clin Epidemiol. 2010 May;63(5):513–23. [PubMed: 19595577]
86.
Atkins D, Chang SM, Gartlehner G, et al. Assessing applicability when comparing medical interventions: AHRQ and the Effective Health Care Program. J Clin Epidemiol. 2011 Nov;64(11):1198–207. [PubMed: 21463926]
87.
Bogner HR, de Vries HF. Integrating type 2 diabetes mellitus and depression treatment among African Americans: a randomized controlled pilot trial. Diabetes Educ. 2010 Mar–Apr;36(2):284–92. [PMC free article: PMC2858776] [PubMed: 20040705]
88.
Grant RW, Devita NG, Singer DE, et al. Improving adherence and reducing medication discrepancies in patients with diabetes. Ann Pharmacother. 2003 Jul–Aug;37(7–8):962–9. [PubMed: 12841801]
89.
Lin EH, Katon W, Rutter C, et al. Effects of enhanced depression treatment on diabetes self-care. Ann Fam Med. 2006 Jan–Feb;4(1):46–53. [PMC free article: PMC1466986] [PubMed: 16449396]
90.
Wolever RQ, Dreusicke M, Fikkan J, et al. Integrative health coaching for patients with type 2 diabetes: a randomized clinical trial. Diabetes Educ. 2010 Jul–Aug;36(4):629–39. [PubMed: 20534872]
91.
Pearce KA, Love MM, Shelton BJ, et al. Cardiovascular risk education and social support (CaRESS): report of a randomized controlled trial from the Kentucky Ambulatory Network (KAN) J Am Board Fam Med. 2008 Jul–Aug;21(4):269–81. [PubMed: 18612053]
92.
Mann DM, Ponieman D, Montori VM, et al. The Statin Choice decision aid in primary care: a randomized trial. Patient Educ Couns. 2010 Jul;80(1):138–40. [PubMed: 19959322]
93.
Weymiller AJ, Montori VM, Jones LA, et al. Helping patients with type 2 diabetes mellitus make treatment decisions: statin choice randomized trial. Arch Intern Med. 2007 May 28;167(10):1076–82. [PubMed: 17533211]
94.
Jones LA, Weymiller AJ, Shah N, et al. Should clinicians deliver decision aids? Further exploration of the statin choice randomized trial results. Med Decis Making. 2009 Jul–Aug;29(4):468–74. [PubMed: 19605885]
95.
Guthrie RM. The effects of postal and telephone reminders on compliance with pravastatin therapy in a national registry: results of the first myocardial infarction risk reduction program. Clin Ther. 2001 Jun;23(6):970–80. [PubMed: 11440296]
96.
Johnson SS, Driskell MM, Johnson JL, et al. Transtheoretical model intervention for adherence to lipid-lowering drugs. Dis Manag. 2006 Apr;9(2):102–14. [PubMed: 16620196]
97.
Powell KM, Edgren B. Failure of educational videotapes to improve medication compliance in a health maintenance organization. Am J Health Syst Pharm. 1995 Oct 15;52(20):2196–9. [PubMed: 8564589]
98.
Schectman G, Hiatt J, Hartz A. Telephone contacts do not improve adherence to niacin or bile acid sequestrant therapy. Ann Pharmacother. 1994 Jan;28(1):29–35. [PubMed: 8123955]
99.
Stacy JN, Schwartz SM, Ershoff D, et al. Incorporating tailored interactive patient solutions using interactive voice response technology to improve statin adherence: results of a randomized clinical trial in a managed care setting. Popul Health Manag. 2009 Oct;12(5):241–54. [PubMed: 19848566]
100.
Schneider PJ, Murphy JE, Pedersen CA. Impact of medication packaging on adherence and treatment outcomes in older ambulatory patients. J Am Pharm Assoc. 2003 2008 Jan–Feb;48(1):58–63. [PubMed: 18192132]
101.
Bogner HR, de Vries HF. Integration of depression and hypertension treatment: a pilot, randomized controlled trial. Ann Fam Med. 2008 Jul–Aug;6(4):295–301. [PMC free article: PMC2478504] [PubMed: 18626028]
102.
Rudd P, Miller NH, Kaufman J, et al. Nurse management for hypertension. A systems approach. Am J Hypertens. 2004 Oct;17(10):921–7. [PubMed: 15485755]
103.
Wakefield BJ, Holman JE, Ray A, et al. Effectiveness of home telehealth in comorbid diabetes and hypertension: a randomized, controlled trial. Telemed J E Health. 2011 May;17(4):254–61. [PubMed: 21476945]
104.
Carter BL, Ardery G, Dawson JD, et al. Physician and pharmacist collaboration to improve blood pressure control. Arch Intern Med. 2009 Nov 23;169(21):1996–2002. [PMC free article: PMC2882170] [PubMed: 19933962]
105.
Hunt JS, Siemienczuk J, Pape G, et al. A randomized controlled trial of team-based care: impact of physician-pharmacist collaboration on uncontrolled hypertension. J Gen Intern Med. 2008 Dec;23(12):1966–72. [PMC free article: PMC2596500] [PubMed: 18815843]
106.
Bosworth HB, Olsen MK, Neary A, et al. Take Control of Your Blood Pressure (TCYB) study: a multifactorial tailored behavioral and educational intervention for achieving blood pressure control. Patient Educ Couns. 2008 Mar;70(3):338–47. [PMC free article: PMC2276731] [PubMed: 18164894]
107.
Bosworth HB, Olsen MK, Dudley T, et al. The Take Control of Your Blood pressure (TCYB) study: Study design and methodology. Contemporary Clinical Trials. 2007;28(1):33–47. [PubMed: 16996808]
108.
Bosworth HB, Olsen MK, Gentry P, et al. Nurse administered telephone intervention for blood pressure control: a patient-tailored multifactorial intervention. Patient Educ Couns. 2005 Apr;57(1):5–14. [PubMed: 15797147]
109.
Friedman RH, Kazis LE, Jette A, et al. A telecommunications system for monitoring and counseling patients with hypertension. Impact on medication adherence and blood pressure control. Am J Hypertens. 1996 Apr;9(4 Pt 1):285–92. [PubMed: 8722429]
110.
Johnson SS, Driskell MM, Johnson JL, et al. Efficacy of a transtheoretical model-based expert system for antihypertensive adherence. Dis Manag. 2006 Oct;9(5):291–301. [PubMed: 17044763]
111.
Solomon DK, Portner TS, Bass GE, et al. Clinical and economic outcomes in the hypertension and COPD arms of a multicenter outcomes study. J Am Pharm Assoc (Wash) 1998 Sep–Oct;38(5):574–85. [PubMed: 9782691]
112.
Gourley GA, Portner TS, Gourley DR, et al. Humanistic outcomes in the hypertension and COPD arms of a multicenter outcomes study. J Am Pharm Assoc (Wash) 1998 Sep–Oct;38(5):586–97. [PubMed: 9782692]
113.
Vivian EM. Improving blood pressure control in a pharmacist-managed hypertension clinic. Pharmacotherapy. 2002 Dec;22(12):1533–40. [PubMed: 12495164]
114.
Powers BJ, Danus S, Grubber JM, et al. The effectiveness of personalized coronary heart disease and stroke risk communication. Am Heart J. 2011;161(4):673–80. [PubMed: 21473965]
115.
Fulmer TT, Feldman PH, Kim TS, et al. An intervention study to enhance medication compliance in community-dwelling elderly individuals. J Gerontol Nurs. 1999 Aug;25(8):6–14. [PubMed: 10711101]
116.
Murray MD, Young J, Hoke S, et al. Pharmacist intervention to improve medication adherence in heart failure: a randomized trial. Ann Intern Med. 2007 May 15;146(10):714–25. [PubMed: 17502632]
117.
Rich MW, Gray DB, Beckham V, et al. Effect of a multidisciplinary intervention on medication compliance in elderly patients with congestive heart failure. Am J Med. 1996 Sep;101(3):270–6. [PubMed: 8873488]
118.
Ross SE, Moore LA, Earnest MA, et al. Providing a web-based online medical record with electronic communication capabilities to patients with congestive heart failure: randomized trial. J Med Internet Res. 2004 May 14;6(2):e12. [PMC free article: PMC1550594] [PubMed: 15249261]
119.
Smith DH, Kramer JM, Perrin N, et al. A randomized trial of direct-to-patient communication to enhance adherence to beta-blocker therapy following myocardial infarction. Arch Intern Med. 2008 Mar 10;168(5):477–83. discussion 83; quiz 47. [PubMed: 18332291]
120.
Bender BG, Apter A, Bogen DK, et al. Test of an interactive voice response intervention to improve adherence to controller medications in adults with asthma. J Am Board Fam Med. 2010 Mar–Apr;23(2):159–65. [PubMed: 20207925]
121.
Berg J, Dunbar-Jacob J, Sereika SM. An evaluation of a self-management program for adults with asthma. Clin Nurs Res. 1997 Aug;6(3):225–38. [PubMed: 9281927]
122.
Janson SL, Fahy JV, Covington JK, et al. Effects of individual self-management education on clinical, biological, and adherence outcomes in asthma. Am J Med. 2003 Dec 1;115(8):620–6. [PubMed: 14656614]
123.
Janson SL, McGrath KW, Covington JK, et al. Individualized asthma self-management improves medication adherence and markers of asthma control. J Allergy Clin Immunol. 2009 Apr;123(4):840–6. [PMC free article: PMC2729175] [PubMed: 19348923]
124.
Schaffer SD, Tian L. Promoting adherence: effects of theory-based asthma education. Clin Nurs Res. 2004 Feb;13(1):69–89. [PubMed: 14768768]
125.
Weinberger M, Murray MD, Marrero DG, et al. Effectiveness of pharmacist care for patients with reactive airways disease: a randomized controlled trial. JAMA. 2002 Oct 2;288(13):1594–602. [PubMed: 12350190]
126.
Williams LK, Peterson EL, Wells K, et al. A cluster-randomized trial to provide clinicians inhaled corticosteroid adherence information for their patients with asthma. J Allergy Clin Immunol. 2010 Aug;126(2):225–31. 31 e1–4. [PMC free article: PMC2917519] [PubMed: 20569973]
127.
Wilson SR, Strub P, Buist AS, et al. Shared treatment decision making improves adherence and outcomes in poorly controlled asthma. Am J Respir Crit Care Med. 2010 Mar 15;181(6):566–77. [PMC free article: PMC2841026] [PubMed: 20019345]
128.
Rickles NM, Svarstad BL, Statz-Paynter JL, et al. Pharmacist telemonitoring of antidepressant use: effects on pharmacist-patient collaboration. J Am Pharm Assoc. 2003 2005 May–Jun;45(3):344–53. [PubMed: 15991756]
129.
Simon GE, Ludman EJ, Operskalski BH. Randomized trial of a telephone care management program for outpatients starting antidepressant treatment. Psychiatr Serv. 2006 Oct;57(10):1441–5. [PubMed: 17035563]
130.
Katon W, Rutter C, Ludman EJ, et al. A randomized trial of relapse prevention of depression in primary care. Arch Gen Psychiatry. 2001 Mar;58(3):241–7. [PubMed: 11231831]
131.
Ludman E, Katon W, Bush T, et al. Behavioural factors associated with symptom outcomes in a primary care-based depression prevention intervention trial. Psychol Med. 2003 Aug;33(6):1061–70. [PubMed: 12946090]
132.
Von Korff M, Katon W, Rutter C, et al. Effect on disability outcomes of a depression relapse prevention program. Psychosom Med. 2003 Nov–Dec;65(6):938–43. [PubMed: 14645770]
133.
Capoccia KL, Boudreau DM, Blough DK, et al. Randomized trial of pharmacist interventions to improve depression care and outcomes in primary care. Am J Health Syst Pharm. 2004 Feb 15;61(4):364–72. [PubMed: 15011764]
134.
Katon W, Von Korff M, Lin E, et al. Collaborative management to achieve treatment guidelines. Impact on depression in primary care. JAMA. 1995 Apr 5;273(13):1026–31. [PubMed: 7897786]
135.
Katon W, Robinson P, Von Korff M, et al. A multifaceted intervention to improve treatment of depression in primary care. Arch Gen Psychiatry. 1996 Oct;53(10):924–32. [PubMed: 8857869]
136.
Katon W, Von Korff M, Lin E, et al. Stepped collaborative care for primary care patients with persistent symptoms of depression: A randomized trial. Arch Gen Psychiatry. 1999;56(12):1109–15. [PubMed: 10591288]
137.
Katon W, Russo J, Von Korff M, et al. Long-term effects of a collaborative care intervention in persistently depressed primary care patients. J Gen Intern Med. 2002 Oct;17(10):741–8. [PMC free article: PMC1495114] [PubMed: 12390549]
138.
Pyne JM, Fortney JC, Curran GM, et al. Effectiveness of collaborative care for depression in human immunodeficiency virus clinics. Arch Intern Med. 2011 Jan 10;171(1):23–31. [PubMed: 21220657]
139.
Hoffman L, Enders J, Luo J, et al. Impact of an antidepressant management program on medication adherence. Am J Manag Care. 2003 Jan;9(1):70–80. [PubMed: 12549816]
140.
Okeke CO, Quigley HA, Jampel HD, et al. Interventions improve poor adherence with once daily glaucoma medications in electronically monitored patients. Ophthalmology. 2009 Dec;116(12):2286–93. [PMC free article: PMC2787727] [PubMed: 19815286]
141.
Berger BA, Liang H, Hudmon KS. Evaluation of software-based telephone counseling to enhance medication persistency among patients with multiple sclerosis. J Am Pharm Assoc. 2003 2005 Jul–Aug;45(4):466–72. [PubMed: 16128502]
142.
Rudd RE, Blanch DC, Gall V, et al. A randomized controlled trial of an intervention to reduce low literacy barriers in inflammatory arthritis management. Patient Educ Couns. 2009 Jun;75(3):334–9. [PMC free article: PMC2748845] [PubMed: 19345053]
143.
Waalen J, Bruning AL, Peters MJ, et al. A telephone-based intervention for increasing the use of osteoporosis medication: a randomized controlled trial. Am J Manag Care. 2009 Aug;15(8):e60–70. [PubMed: 19659407]
144.
Montori VM, Shah ND, Pencille LJ, et al. Use of a decision aid to improve treatment decisions in osteoporosis: the osteoporosis choice randomized trial. Am J Med. 2011 Jun;124(6):549–56. [PubMed: 21605732]
145.
Nietert PJ, Tilley BC, Zhao W, et al. Two pharmacy interventions to improve refill persistence for chronic disease medications: a randomized, controlled trial. Med Care. 2009 Jan;47(1):32–40. [PubMed: 19106728]
146.
Schnipper JL, Kirwin JL, Cotugno MC, et al. Role of pharmacist counseling in preventing adverse drug events after hospitalization. Arch Intern Med. 2006 Mar 13;166(5):565–71. [PubMed: 16534045]
147.
Taylor CT, Byrd DC, Krueger K. Improving primary care in rural Alabama with a pharmacy initiative. Am J Health Syst Pharm. 2003 Jun 1;60(11):1123–9. [PubMed: 12816022]
148.
Sledge WH, Brown KE, Levine JM, et al. A randomized trial of primary intensive care to reduce hospital admissions in patients with high utilization of inpatient services. Dis Manag. 2006 Dec;9(6):328–38. [PubMed: 17115880]
149.
Chernew ME, Shah MR, Wegh A, et al. Impact of decreasing copayments on medication adherence within a disease management environment. Health Aff (Millwood) 2008 Jan–Feb;27(1):103–12. [PubMed: 18180484]
150.
Choudhry NK, Fischer MA, Avorn J, et al. At Pitney Bowes, value-based insurance design cut copayments and increased drug adherence. Health Aff (Millwood) 2010 Nov;29(11):1995–2001. [PubMed: 21041738]
151.
Zhang Y, Lave JR, Donohue JM, et al. The impact of Medicare Part D on medication adherence among older adults enrolled in Medicare-Advantage products. Med Care. 2010 May;48(5):409–17. [PubMed: 20393360]
152.
Maciejewski ML, Farley JF, Parker J, et al. Copayment reductions generate greater medication adherence in targeted patients. Health Aff (Millwood) 2010 Nov;29(11):2002–8. [PubMed: 21041739]
153.
Choudhry NK, Avorn J, Glynn RJ, et al. Full coverage for preventive medications after myocardial infarction. N Engl J Med. 2011 Dec 1;365(22):2088–97. [PubMed: 22080794]
154.
Gold M, Jacobson G, Damico A, et al. Medicare Advantage enrollment market update Kaiser Family Foundation. Program on Medicare Policy. 2011 Sep:1–13.
155.
Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986 Jan;24(1):67–74. [PubMed: 3945130]
156.
Kaboli P, Hoth A, Carter BL, et al. The VA Enhanced Pharmacy Outpatient Clinic (EPOC) Study: A randomized-controlled pharmacist-physician intervention trial. J Gen Intern Med. 2004 Apr;19(Suppl 1):227.
157.
Rueda S, Park-Wyllie Laura Y, Bayoumi A, et al. Patient support and education for promoting adherence to highly active antiretroviral therapy for HIV/AIDS. Cochrane Database of Systematic Reviews. 2006;(3) [PubMed: 16855968]
158.
Davidoff F, Batalden P, Stevens D, et al. Publication guidelines for quality improvement in health care: evolution of the SQUIRE project. Quality & safety in health care. 2008 Oct;17 Suppl 1:i3–9. [PMC free article: PMC2773518] [PubMed: 18836063]
159.
Begg C, Cho M, Eastwood S, et al. Improving the quality of reporting of randomized controlled trials. The CONSORT statement. JAMA. 1996 Aug 28;276(8):637–9. [PubMed: 8773637]
PubReader format: click here to try

Views

  • PubReader
  • Print View
  • Cite this Page
  • PDF version of this title (4.2M)

Related information

  • PMC
    PubMed Central citations
  • PubMed
    Links to pubmed

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...